Shivkamal Impex Q1 Results: Net profit falls 33% YoY to ₹5.20 lakh

1 min read     Updated on 12 Aug 2026, 07:50 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Shivkamal Impex Ltd posted a net profit of ₹5.20 lakh for Q1FY26, down 33% YoY. Revenue from operations fell to ₹12.37 lakh as interest income contracted. Expenses rose to ₹5.42 lakh, impacting profitability despite nil finance costs.

powered bylight_fuzz_icon
48090041

*this image is generated using AI for illustrative purposes only.

Shivkamal Impex reported a net profit of ₹5.20 lakh for the quarter ended June 30, 2026, marking a decline from ₹7.81 lakh in the corresponding period of FY25. The company’s total revenue from operations stood at ₹12.37 lakh, down from ₹13.25 lakh in Q1FY25.

The Board of Directors approved the unaudited financial results on August 12, 2026. The figures were reviewed by Multi Associates, Chartered Accountants, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Shivkamal Impex, primarily engaged in financial services, saw its interest income drop to ₹12.37 lakh from ₹13.25 lakh in the previous year’s quarter. This reduction in top-line revenue contributed to a lower profit before tax, which stood at ₹6.95 lakh compared to ₹10.44 lakh in Q1FY25.

Total expenses for the quarter were ₹5.42 lakh, an increase from ₹2.81 lakh in Q1FY25. Employee benefit expenses rose to ₹1.22 lakh from ₹0.90 lakh, while other expenses increased significantly to ₹4.10 lakh from ₹1.85 lakh. Finance costs and impairment charges were nil for the current quarter.

Metric Q1FY26 (₹ in lakhs) Q1FY25 (₹ in lakhs)
Revenue from Operations 12.37 13.25
Total Expenses 5.42 2.81
Profit Before Tax 6.95 10.44
Net Profit 5.20 7.81

What the Numbers Show

The divergence between revenue contraction and expense expansion highlights margin pressure. While revenue fell by approximately 7% year-on-year, total expenses nearly doubled, driven largely by a rise in 'other expenses' and employee benefits. This structural shift resulted in the profit before tax declining by over 30%, outpacing the modest drop in operating income.

Auditor Review

Multi Associates, Chartered Accountants, issued a limited review report stating that nothing came to their attention to suggest the financial statements contain material misstatement. The review was conducted in accordance with Standard on Review Engagement (SRE) 2410.

The company has no subsidiaries, associates, or joint ventures. The paid-up equity share capital remains at ₹100.56 lakh.

Historical Stock Returns for Shivkamal Impex

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

What specific operational changes or market factors contributed to the near-doubling of 'other expenses' in Q1FY26?

How does management plan to address the widening gap between revenue contraction and expense growth to restore margin stability?

Given the decline in interest income, are there strategic shifts in the company's financial services portfolio or asset allocation for FY26?

Shivkamal Impex amends code for fair disclosure of UPSI

1 min read     Updated on 29 May 2026, 10:04 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Shivkamal Impex Limited approved an amendment to its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information on May 29, 2026. The revision complies with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2025. The Board designated the Compliance Officer as the Chief Investor Relations Officer to manage UPSI dissemination and mandated the maintenance of a structured digital database for tracking shared information.

powered bylight_fuzz_icon
41611112

*this image is generated using AI for illustrative purposes only.

Shivkamal Impex Limited approved an amendment to its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) on May 29, 2026. The revision aligns the company's internal policies with the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2025, which became effective on June 10, 2025. The updated code supersedes all previous versions and is effective immediately from the date of board approval.

The Board of Directors sanctioned the amendment during its meeting held on May 29, 2026, pursuant to Regulation 8 read with Schedule A of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company has communicated the revised code to BSE Ltd and made it available on its official website. Rupali Kulshrestha, Company Secretary and Compliance Officer, confirmed the implementation of the amended framework.

Key Provisions of the Amended Code

The amended code mandates that the Compliance Officer be designated as the Chief Investor Relations Officer (CIRO) to oversee the dissemination of UPSI. This officer is responsible for determining whether information constitutes UPSI and ensuring uniform, universal dissemination to prevent selective disclosure. Price-sensitive information must be communicated to stock exchanges before being released to investors, analysts, or the media.

The policy emphasizes handling UPSI on a need-to-know basis, restricting access to individuals where communication is necessary for legitimate purposes or legal obligations. A structured digital database containing the nature of UPSI and details of persons sharing or receiving it must be maintained with adequate internal controls, including time stamping and audit trails.

Disclosure and Compliance

The company is required to promptly disseminate any UPSI that is disclosed selectively or inadvertently to make it generally available. The CIRO must ensure appropriate responses to queries on news reports and requests for verification of market rumors by regulatory authorities. Additionally, transcripts or records of proceedings of meetings with analysts will be made available on the company's website to ensure official documentation of disclosures.

Historical Stock Returns for Shivkamal Impex

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%0.0%

How will the dual role of Compliance Officer and Chief Investor Relations Officer impact the company's governance structure?

What technological upgrades will be required to implement the structured digital database with time stamping and audit trails?

How might the immediate dissemination of UPSI to exchanges before analysts affect the company's relationship with the investment community?

More News on Shivkamal Impex

1 Year Returns:0.00%